“…These include mild-to-moderate impairment in a number of frontally mediated cognitive functions including sustained attention, working memory and response inhibition (al-Adawi & Powell, 1997; Ashare, Falcone, & Lerman, 2014; Dawkins, Powell, West, Powell, & Pickering, 2007; Powell, Dawkins, & Davis, 2002; Wesnes, Edgar, Kezic, Salih, & de Boer, 2013). The reversal of these withdrawal-associated cognitive deficits has been proposed as a potential target for medication development efforts aimed at increasing smoking cessation rates (Ashare et al, 2016; Ashare & Schmidt, 2014). …”